Proprietary capital
Separating the signal from the noise.
A proprietary private venture firm bridging innovations in fintech and biotech, one venture at a time. We invest globally. No external clients.
- Capital
- Balance sheet
- Sectors
- Fintech · Biotech
- Stage
- Early & late
The house
At Profluent Ventures, we are collaborators and catalysts for industry growth. Innovation thrives through genuine partnership. We champion both early and late-stage companies, especially in fintech and biotech, and we stay involved after the check clears. We operate as a proprietary venture firm. We do not raise outside LP capital on this site and we do not provide investment advisory services. Inquiries from founders and counterparties are welcome.
-
Partnership first
We align expertise, resources, and vision with founders and industry counterparties.
-
Proprietary capital
We invest our own capital. No external clients. No managed accounts.
-
Signal over noise
We underwrite with the same falsification discipline used across the Profluent companies.
-
Durable companies
We look for ventures that can compound through cycles, not just a single funding round.
Where attention goes
Fintech
Payments, markets infrastructure, blockchain, web3, and financial institutions. We look for systems that make capital move with more integrity and less friction.
Biotech
Therapeutics, devices, and scientific platforms that can move from concept to clinic. We underwrite both the science and the operating company around it.
The book
Selected investments. This is not a complete list. Some of these are personal investments of ours as well.
| Name | Sector |
|---|---|
| SpaceX | Space & aerospace |
| xAI | Artificial intelligence |
| Groq | AI hardware |
| Perplexity AI | Artificial intelligence |
| Cerebras Systems | Semiconductors |
| Physical Intelligence | AI & robotics |
| Apptronik | Robotics |
| Discord | Social |
| Deribit | Cryptocurrency |
| Hidden Road | Financial |
| Paradigm | Cryptocurrency |
| Loyal | Biotechnology |
30+ portfolio companies. Tens of millions invested. Names above are illustrative of the book. This is not an offer of securities.
General partner
General Partner
Jessica Mouler
Leads investment strategy across fintech and biotech, with a data-driven underwriting process and long-horizon partnerships with founders.
Forbes 30 Under 30 Finance · 2020
Write to the house
Founders, counterparties, and partners — reach us by email. We will respond as soon as possible.
Not a fundraise, not an advisory desk
Disclaimer: Profluent Ventures is a proprietary venture firm. This site is informational only and does not constitute investment advice, an offer, or solicitation. We do not accept or manage customer funds and we do not provide investment advisory services. Past performance is not indicative of future results.